Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 122

Sort by

Sort Order Select

Journal Articles

Leukemia secondary to myeloproliferative neoplasms

Andrew J. Dunbar, Raajit K. Rampal, Ross Levine

Blood (2020) 136 (1): 61–70.

https://doi.org/10.1182/blood.2019000943

Published: 2020

Journal Articles

Introduction to a review series on secondary leukemia

Jean Soulier

Blood (2020) 136 (1): 1.

https://doi.org/10.1182/blood.2019004171

Published: 2020

Journal Articles

Genetics of progression from MDS to secondary leukemia

Andrew J. Menssen, Matthew J. Walter

Blood (2020) 136 (1): 50–60.

https://doi.org/10.1182/blood.2019000942

Published: 2020

Journal Articles

Secondary leukemia in patients with germline transcription factor mutations ( RUNX1 , GATA2 , CEBPA )

Anna L. Brown, Christopher N. Hahn, Hamish S. Scott

Blood (2020) 136 (1): 24–35.

https://doi.org/10.1182/blood.2019000937

Published: 2020

Includes: Supplemental data

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 45.

https://doi.org/10.1182/blood-2019-124765

Published: 2019

Journal Articles

Impact of a Risk-Adapted Treatment Approach in Pediatric AML: A Report of the AML-BFM Registry 2012

Mareike Rasche, MD, Emma Steidel, Denise Kondryn, Nils Von Neuhoff, PhD, Lucie Sramkova, MD, Ursula Creutzig, MD, Michael Dworzak, MD, Dirk Reinhardt, MD

Blood (2019) 134 (Supplement_1): 293.

https://doi.org/10.1182/blood-2019-130969

Published: 2019

Journal Articles

Local Field Radiotherapy Induced Therapy Related Myeloid Neoplasms and Bone Marrow Suppression

Dina Sameh Soliman, MD MB, MMSc, Ahmad Al-Sabbagh, MD, Firyal Ibrahim, MD, Halima El-Omri, MD, Mohamed A Yassin, MBBS, MSc, Aliaa Amer, MD

Blood (2019) 134 (Supplement_1): 5113.

https://doi.org/10.1182/blood-2019-131683

Published: 2019

Journal Articles

High Dose Flamsa, CLAG or FLAG-Based Sequential Conditioning Regimen Followed By Allogeneic Hematopoietic Transplantation Results in Favorable Outcome for High Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasia Patients: A Multicenter Study in Singapore

Yin Jie Koh, Michelle Poon, MBBS, MRCP, FRCPATH, Yeh Ching Linn, MBBS, MRCP, William YK Hwang, MBBS, FRCP, Elson Neo, Aloysius YL Ho, MBBS,FRCP,FRCPath, Lip Kun Tan, MBBS, FRCP, FRCPath, Liang Piu Koh, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 4509.

https://doi.org/10.1182/blood-2019-125246

Published: 2019

Journal Articles

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

Barbara Spitzer, MD, Gunes Gundem, PhD, Noushin Farnoud, PhD, Nathan Millard, MD, Erin McGovern, BA, Minal Patel, BA, Max Levine, MS, Juan Medina, MS, Yangyu Zhou, BS, Juan E. Arango Ossa, BS, Michael Francis Walsh, MD, Ross L. Levine, MD, Irene Y. Cheung, ScD, Scott A. Armstrong, MD PhD, Nai-Kong V. Cheung, MD PhD, Elli Papaemmanuil, PhD

Blood (2018) 132 (Supplement 1): 291.

https://doi.org/10.1182/blood-2018-99-120005

Published: 2018

Journal Articles

Adding Midostaurin to Intensive Chemotherapy in FLT3-Positive AML Patients. Results from a Multicenter Historical-Controlled Study

Tamar Berger, MD, Yakir Moshe, MD, Shilo Yaari, Ilana Hellmann, MD, Adina Aviram, PhD, Pia Raanani, Ron Ram, MD, Yishai Ofran, MD, Ofir Wolach, MD

Blood (2018) 132 (Supplement 1): 4005.

https://doi.org/10.1182/blood-2018-99-114154

Published: 2018

Journal Articles

Augmentation of the Acute Myeloid Leukemia-Composite Model (AML-CM) with Performance Status and Secondary Leukemia

Sarah Elsayed, MD, Barry E. Storer, PhD, Bruno C. Medeiros, MD, Mona Ahmed Asslan, MSc, Ylinne Lynch, MD, Jennifer E. Nyland, PhD, Pamela S. Becker, MD, Mary-Elizabeth M. Percival, MD, Elihu H. Estey, MD, Mohamed L. Sorror, MD MSc

Blood (2018) 132 (Supplement 1): 3992.

https://doi.org/10.1182/blood-2018-99-117415

Published: 2018

Journal Articles

Deletion of the p53 Target Gene PUMA Prevents Bone Marrow Failure in a Dyskeratosis Congenita Mouse Model

Miriam Erlacher, MD PhD, Christian Molnar, Julia Miriam Weiss, Sheila Bohler, Doris Steinemann, PhD, Gudrun Göhring, MD, Andreas Villunger, Verena Labi, Charlotte Niemeyer, MD, Alexander Egle, MD

Blood (2018) 132 (Supplement 1): 648.

https://doi.org/10.1182/blood-2018-99-116349

Published: 2018

Journal Articles

A Small Molecular Agonist of Histone Demethylase KDM3B Selectively Represses MLL -Rearranged Acute Leukemia

Xin Xu, PhD, Wilhelm G Dirks, PhD, Hans G. Drexler, MD PhD, Zhenbo Hu, MD PhD

Blood (2018) 132 (Supplement 1): 4682.

https://doi.org/10.1182/blood-2018-99-112018

Published: 2018

Journal Articles

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia

Paul Lin, MD PhD, Lauren Westfall Veltri, MD, Katy Rezvani, MD PhD, Betul Oran, MD MS, Sairah Ahmed, MD, Gheath Alatrash, DO, PhD, Rohtesh S. Mehta, MD MPH, MS, Gabriela Rondon, MD, Partow Kebriaei, MD, Uday Popat, MD, Yago Nieto, MD PhD, Chitra Hosing, MD, Roy B Jones, MD PhD, Muzaffar H. Qazilbash, MD, Issa F. Khouri, Elizabeth J. Shpall, MD, Richard E Champlin, MD, David Marin, MD

Blood (2018) 132 (Supplement 1): 4667.

https://doi.org/10.1182/blood-2018-99-112749

Published: 2018

Journal Articles

Favorable Outcome of Sequential HLA-Haploidentical Transplantation Using Ptcy As GvHD Prophylaxis in High Risk AML and MDS of the Elderly

Alessia Fraccaroli, MD, Dusan Prevalsek, Sarah Elena Häbe, Veit Bücklein, MD, Christoph Schulz, MD, Heidrun Drolle, Susanne Fritsch, Georg Ledderose, Michael von Bergwelt, MD, Wolfgang Hiddemann, PhD, Johanna Tischer

Blood (2018) 132 (Supplement 1): 3458.

https://doi.org/10.1182/blood-2018-99-119103

Published: 2018

Journal Articles

HAX1 Associated Congenital Neutropenia: A 25 Year Long-Term Analysis of the European Scnir Cohort

Cornelia Zeidler, Sabine Mellor-Heineke, MD, Maksim Klimiankou, Julia Skokowa, Karl Welte, MD PhD

Blood (2017) 130 (Supplement 1): 3566.

https://doi.org/10.1182/blood.V130.Suppl_1.3566.3566

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Marina Diaz Beya, MD, Myriam Labopin, MD PhD, Johan Maertens, Alijurf Mahmoud, MD, Alois Gratwohl, MD, Dietrich W Beelen, MD PhD, Harry C. Schouten, MD, Gérard Socié, MDPhD, Antonius VMB Schattenberg, MD PhD, Rainer Schwerdtfeger, MD, Liisa Volin, Mauricette Michallet, MD PhD, Emmanuelle Polge, Mohamad Mohty, MD PhD, Jordi Esteve, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 596.

https://doi.org/10.1182/blood.V130.Suppl_1.596.596

Published: 2017

Journal Articles

Prognostic Index for Survival in Adult Patients with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia (ALL)

Blood (2017) 130 (Supplement 1): 1435.

https://doi.org/10.1182/blood.V130.Suppl_1.1435.1435

Published: 2017

Journal Articles

Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Susan M. O'Brien, MD, Farhad Ravandi, MBBS, Marina Konopleva, MD PhD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, William G Wierda, MD PhD, Naval Daver, MD, Alessandra Ferrajoli, MD, Koichi Takahashi, MD, Preetesh Jain, MBBS,MDDM,PhD, Mary B. Rios, RN, Sherry Pierce, BSN, BA, Elias J. Jabbour, MD, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 1609.

https://doi.org/10.1182/blood.V130.Suppl_1.1609.1609

Published: 2017

Journal Articles

Effect of Anthracycline Dose on Acute Anthracycline Induced Cardiotoxicity in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation

Oren Pasvolsky, MD, Olga Morelli, MD, Uri Rozovski, Moti Vaturi, MD, Ofir Wolach, MD, Irina Amitai, MD, Iuliana Vaxman, MD, Roy Ratzon, MD, Moshe Yeshurun, Zaza Iakobishvili, MD, Ran Kornowski, MD, Pia Raanani

Blood (2017) 130 (Supplement 1): 3861.

https://doi.org/10.1182/blood.V130.Suppl_1.3861.3861

Published: 2017

NARROW

Leukemia secondary to myeloproliferative neoplasms

Introduction to a review series on secondary leukemia

Genetics of progression from MDS to secondary leukemia

Secondary leukemia in patients with germline transcription factor mutations ( RUNX1 , GATA2 , CEBPA )

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT

Impact of a Risk-Adapted Treatment Approach in Pediatric AML: A Report of the AML-BFM Registry 2012

Local Field Radiotherapy Induced Therapy Related Myeloid Neoplasms and Bone Marrow Suppression

High Dose Flamsa, CLAG or FLAG-Based Sequential Conditioning Regimen Followed By Allogeneic Hematopoietic Transplantation Results in Favorable Outcome for High Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasia Patients: A Multicenter Study in Singapore

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

Adding Midostaurin to Intensive Chemotherapy in FLT3-Positive AML Patients. Results from a Multicenter Historical-Controlled Study

Augmentation of the Acute Myeloid Leukemia-Composite Model (AML-CM) with Performance Status and Secondary Leukemia

Deletion of the p53 Target Gene PUMA Prevents Bone Marrow Failure in a Dyskeratosis Congenita Mouse Model

A Small Molecular Agonist of Histone Demethylase KDM3B Selectively Represses MLL -Rearranged Acute Leukemia

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia

Favorable Outcome of Sequential HLA-Haploidentical Transplantation Using Ptcy As GvHD Prophylaxis in High Risk AML and MDS of the Elderly

HAX1 Associated Congenital Neutropenia: A 25 Year Long-Term Analysis of the European Scnir Cohort

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Prognostic Index for Survival in Adult Patients with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia (ALL)

Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)

Effect of Anthracycline Dose on Acute Anthracycline Induced Cardiotoxicity in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only